Please use this identifier to cite or link to this item: https://www.arca.fiocruz.br/handle/icict/15400
Title: New insights in Trypanosoma cruzi proteomic map: further posttranslational modifications and potential drug targets in Y strain epimastigotes
Authors: Beghini, Daniela Gois
Ferreira, André Teixeira da Silva
Almeida, Vivian Corrêa de
Caminha, Marcelle Almeida
Silva Jr., Floriano Paes
Perales, Jonas
Menna-Barreto, Rubem Figueiredo Sadok
Affilliation: Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Toxinologia. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Toxinologia. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Bioquímica de Proteínas e Peptídeos. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Biologia Celular. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Bioquímica de Proteínas e Peptídeos. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Toxinologia. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Biologia Celular. Rio de Janeiro, RJ, Brasil.
Abstract: Chagas´ disease is a neglected sickness endemic in Latin America, caused by the protozoa Trypanosoma cruzi. 1e current treatment for the disease is unsatisfactory, and the development of potent compounds for novel molecular targets is critical. In this framework, proteomics could be a powerful tool in the evaluation of possible candidates for drug intervention. In this work, a two-dimensional electrophoresis (2- DE) and mass spectrometry (MS) approaches were employed in T. cruzi epimastigotes (Y strain). Di8erent gel staining protocols (Coomassie Blue, Pro-Q-Diamond and Pro-Q-Emerald) were performed to assess the protein content and possible post-translational modi)cations of this parasite. Here, 78 most intense spots were identi)ed by Coomassie staining, 22 by Pro-Q-Diamond (phosphoproteins) and 15 by Pro-QEmerald (glycoproteins). Compared with the results of other large-scale T. cruzi proteomic studies, 15 novel proteins were identi)ed here using MALDI-TOF/TOF, and 12 of these have not yet been described at the protein level. Functional analysis of the identi)ed proteins pointed to protein metabolism, and the localisation prediction indicated cytosol as the most prevalent localisation of these proteins. Eight proteins presented no similarity to human sequences and thus represent a group of promising biomolecules for chemotherapy intervention. Our data provides novel insights in the metabolic pathways of T. cruzi, which could aid in the discovery of alternative drugs for Chagas´ disease.
Keywords: Trypanosoma cruzi
Chagas Disease
Chemotherapy
Post-translational modi)cations
Mass spectometry
Proteomics
keywords: Trypanosoma cruzi
Doença de Chagas
Quimioterapia
Proteômica
Espectometria de massa
Issue Date: 2012
Citation: BEGHINI, Daniela Gois; et al. New insights in Trypanosoma cruzi proteomic map: further posttranslational modifications and potential drug targets in Y strain epimastigotes. Journal of Integratred Omics, v.2, n.2, p.106-113, Dec. 2012.
DOI: 10.5584/jiomics.v2i2.107
ISSN: 2182-0287
Copyright: open access
Appears in Collections:IOC - Artigos de Periódicos

Files in This Item:
File Description SizeFormat 
daniela_beghini_etal_IOC_2012.pdf3.36 MBAdobe PDFView/Open


FacebookTwitterDeliciousLinkedInGoogle BookmarksBibTex Format mendeley Endnote DiggMySpace

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.